Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig 6 Ar1 B
Devotta A et al. (2023)
|
Xla Wt + nppa MO
NF15 (in situ hybridization)
|
|
|
|
Fig 6 A:r3 BDE
Devotta A et al. (2023)
|
Xla Wt + nppc MO
NF15 (in situ hybridization)
|
|
|
|
Fig. 5 B:c2r1 CD
Devotta A et al. (2023)
|
Xla Wt + npr1 MO
NF15 (in situ hybridization)
|
|
|
|
Fig. 2 CD
Devotta A et al. (2023)
|
Xla Wt + npr3 MO
NF15 (in situ hybridization)
|
|
|
|
Fig. S6 FGH
Mishra-Gorur K et al. (2023)
|
Xtr wt + Tg(traf)T601A
NF16-18 (in situ hybridization)
|
|
|
|
Fig. 2. U, V
Mishra-Gorur K et al. (2023)
|
Xtr Wt + traf1
NF17 (in situ hybridization)
|
|
|
|
Fig. 2. O
Mishra-Gorur K et al. (2023)
|
Xtr wt + traf7 MO
NF16-18 (in situ hybridization)
|
|
|
|
Fig. 5A
Job F et al. (2023)
|
Xla Wt + otud3 MO
NF20 (in situ hybridization)
|
|
|
|
Fig. 5C
Job F et al. (2023)
|
Xla Wt + otud3 MO
NF25 (in situ hybridization)
|
|
|
|
Fig. 5E
Job F et al. (2023)
|
Xla Wt + otud3 MO
NF29/30 (in situ hybridization)
|
|
|